HER2+ Lung Cancer Breakthroughs: Sequencing Therapies and Next-Gen Innovations

from Medical News Podcast · host PeerDirect Publishing

Drs. Herzberg and Yu continue their discussion on emerging clinical data presented at ESMO and WCLC 2025. They highlight recent advancements in HER2-targeted therapies for NSCLC and review new HER2-targeted therapies, international study results, and the promise of evolving targeted approaches for HER2-altered lung cancer.

Episode metadata supplied by the publisher feed · Published Dec 29, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

HER2+ Lung Cancer Breakthroughs: Sequencing Therapies and Next-Gen Innovations

0:00 9:39

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medical News Podcast?

This episode is 9 minutes long.

When was this Medical News Podcast episode published?

This episode was published on December 29, 2025.

Can I download this Medical News Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!